These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 15993850

  • 1. A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.
    Fukami T, Nakajima M, Higashi E, Yamanaka H, McLeod HL, Yokoi T.
    Biochem Pharmacol; 2005 Sep 01; 70(5):801-8. PubMed ID: 15993850
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel duplication type of CYP2A6 gene in African-American population.
    Fukami T, Nakajima M, Yamanaka H, Fukushima Y, McLeod HL, Yokoi T.
    Drug Metab Dispos; 2007 Apr 01; 35(4):515-20. PubMed ID: 17267622
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
    Kwon JT, Nakajima M, Chai S, Yom YK, Kim HK, Yamazaki H, Sohn DR, Yamamoto T, Kuroiwa Y, Yokoi T.
    Pharmacogenetics; 2001 Jun 01; 11(4):317-23. PubMed ID: 11434509
    [Abstract] [Full Text] [Related]

  • 7. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
    Yoshida R, Nakajima M, Nishimura K, Tokudome S, Kwon JT, Yokoi T.
    Clin Pharmacol Ther; 2003 Jul 01; 74(1):69-76. PubMed ID: 12844137
    [Abstract] [Full Text] [Related]

  • 8. A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.
    Ho MK, Mwenifumbo JC, Zhao B, Gillam EM, Tyndale RF.
    Pharmacogenet Genomics; 2008 Jan 01; 18(1):67-75. PubMed ID: 18216723
    [Abstract] [Full Text] [Related]

  • 9. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, Yamazaki H, Yamamoto T, Kuroiwa Y, Yokoi T.
    Clin Pharmacol Ther; 2001 Jan 01; 69(1):72-8. PubMed ID: 11180041
    [Abstract] [Full Text] [Related]

  • 10. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
    Fukami T, Nakajima M, Sakai H, McLeod HL, Yokoi T.
    Pharmacogenomics J; 2006 Jan 01; 6(6):401-12. PubMed ID: 16636685
    [Abstract] [Full Text] [Related]

  • 11. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
    Nakajima M, Kuroiwa Y, Yokoi T.
    Drug Metab Rev; 2002 Nov 01; 34(4):865-77. PubMed ID: 12487152
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
    Peamkrasatam S, Sriwatanakul K, Kiyotani K, Fujieda M, Yamazaki H, Kamataki T, Yoovathaworn K.
    Drug Metab Pharmacokinet; 2006 Dec 01; 21(6):475-84. PubMed ID: 17220563
    [Abstract] [Full Text] [Related]

  • 14. Novel human CYP2A6 alleles confound gene deletion analysis.
    Nakajima M, Yoshida R, Fukami T, McLeod HL, Yokoi T.
    FEBS Lett; 2004 Jul 02; 569(1-3):75-81. PubMed ID: 15225612
    [Abstract] [Full Text] [Related]

  • 15. Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.
    Piliguian M, Zhu AZ, Zhou Q, Benowitz NL, Ahluwalia JS, Sanderson Cox L, Tyndale RF.
    Pharmacogenet Genomics; 2014 Feb 02; 24(2):118-28. PubMed ID: 24305170
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.
    Yoshida R, Nakajima M, Watanabe Y, Kwon JT, Yokoi T.
    Br J Clin Pharmacol; 2002 Nov 02; 54(5):511-7. PubMed ID: 12445030
    [Abstract] [Full Text] [Related]

  • 19. Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted.
    Yamanaka H, Nakajima M, Nishimura K, Yoshida R, Fukami T, Katoh M, Yokoi T.
    Eur J Pharm Sci; 2004 Aug 02; 22(5):419-25. PubMed ID: 15265511
    [Abstract] [Full Text] [Related]

  • 20. Determination of coumarin metabolism in Turkish population.
    Cok I, Aygün Kocabaş N, Cholerton S, Karakaya AE, Sardaş S.
    Hum Exp Toxicol; 2001 Apr 02; 20(4):179-84. PubMed ID: 11393269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.